ArticleHistochemistry and cell biology2025
A bioactive and biodegradable 3D scaffold derived from dermal matrix and enriched with platelet-rich plasma accelerates wound healing in diabetic rats.
Article in Histochemistry and cell biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
Chronic wounds present a major clinical challenge due to impaired healing and prolonged inflammation. This present study aimed to develop and assess a platelet-rich plasma (PRP)-loaded decellularized skin-derived matrix scaffold (SDMP) for enhanced wound healing. A total of 40 male Sprague-Dawley rats were randomly planned to four groups (n = 10 per group): untreated control, PRP, decellularized skin-derived matrix (SDM), and PRP-loaded SDM (SDMP). Full-thickness excisional wounds were created on the dorsal surface of each animal and treatments were applied accordingly. Tissue sampling was performed at two time points-day 7 and day 14 post-injury-with five animals per group euthanized at each time point. Histological evaluations included assessment of newly formed epidermal length, dermal thickness, and collagen density. Biomechanical properties of the regenerated skin were analyzed on day 14 using tensile strength testing. In addition, concentrations of key regenerative (TGF-β1, VEGF) and pro-inflammatory (TNF-α, IL-1β) cytokines in wound tissues were quantified via ELISA. The SDMP-treated group showed significantly enhanced wound closure, improved re-epithelialization and dermal regeneration, greater collagen deposition, and superior tensile strength compared with other groups (p < 0.05). Moreover, cytokine analysis revealed a favorable shift in the wound microenvironment characterized by elevated growth factors and reduced inflammatory mediators (p < 0.05). In conclusion, the PRP-loaded SDMs provides a bioactive and biocompatible platform that significantly improves full-thickness skin diabetic wound healing. This approach holds promise for future translational applications in regenerative medicine.
Indexed as
Identifiers
41351709What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.